EIM
TRIB

Essex Investment Management’s Trinity Biotech TRIB Stock Holding History

Essex Investment Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-280
Closed -$554K – 373
2016
Q3 		$554K Sell
280
-6
-2% -$11.2K 0.09% 241
2016
Q2 		$487K Sell
286
-3
-1% -$5.07K 0.08% 237
2016
Q1 		$506K Sell
289
-45
-13% -$71.6K 0.09% 226
2015
Q4 		$590K Buy
334
+62
+23% +$110K 0.09% 221
2015
Q3 		$467K Buy
272
+111
+69% +$268K 0.08% 234
2015
Q2 		$435K Sell
161
-3
-2% -$7.79K 0.07% 239
2015
Q1 		$473K Sell
164
-2
-1% -$5.54K 0.07% 239
2014
Q4 		$436K Sell
166
-26
-14% -$67.2K 0.06% 243
2014
Q3 		$526K Sell
192
-12
-6% -$39K 0.08% 216
2014
Q2 		$704K Sell
204
-45
-18% -$160K 0.1% 216
2014
Q1 		$905K Buy
249
+24
+11% +$94.4K 0.13% 202
2013
Q4 		$849K Buy
225
+13
+6% +$46.8K 0.12% 215
2013
Q3 		$691K Sell
212
-17
-7% -$49.7K 0.1% 211
2013
Q2 		$579K Buy
+229
New +$570K 0.1% 211

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Essex Investment Management's TRIB Position: Q4 2016 in Review

Essex Investment Management sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 280 shares — an estimated $554K sold.

Essex Investment Management first reported a position in TRIB in Q2 2013 and held it in 14 quarters. The position peaked at $905K in Q1 2014. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • Essex Investment Management reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • Essex Investment Management sold 280 Trinity Biotech shares in Q4 2016, an estimated $554K.
  • Essex Investment Management first reported a position in Trinity Biotech in Q2 2013 and held it in 14 quarters.
  • Essex Investment Management's Trinity Biotech position peaked at $905K in Q1 2014.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on Essex Investment Management's 13F filing for Q4 2016, filed 8 Feb 2017.